Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo

Key Takeaways

• PretestPro completes four eye exams in under two minutes
• VR headset consolidates multiple tests, eliminating separate equipment
• Workflow speeds up threefold, boosting clinic throughput
• AI virtual technician guides patients, ensuring consistent results
• Portable, FDA‑registered device enables remote and waiting‑room testing

Summary

Heru unveiled PretestPro™ at Vision Expo, a VR‑powered diagnostic headset that completes four essential eye‑pre‑tests in under two minutes. The wearable platform merges visual field, near cover test, extraocular motility and quantitative pupillometry into a single, AI‑guided workflow, replacing multiple legacy devices. By automating these exams, PretestPro claims to run three times faster than traditional methods, boosting clinic throughput and patient experience. The FDA‑registered device was demonstrated on the company’s wearable platform in Orlando, FL.

Pulse Analysis

The ophthalmology field has long grappled with fragmented testing equipment that slows patient flow and inflates operational costs. Recent advances in virtual reality and eye‑tracking technology are reshaping this landscape, offering clinicians a unified platform that can capture multiple diagnostic metrics simultaneously. By leveraging a lightweight headset, providers can transition from a roomful of standalone devices to a single, portable solution, aligning with broader healthcare trends toward digitization and point‑of‑care testing.

Heru’s PretestPro™ builds on fifteen years of vision‑science research from the Bascom Palmer Eye Institute, integrating AI‑driven guidance with VR immersion. The system’s virtual technician, named Nora, directs patients through an eight‑point confrontation visual field, near cover test, extraocular motility assessment, and quantitative pupillometry, all while maintaining fixation. Clinical studies cited by the company demonstrate comparable accuracy to conventional perimetry, while delivering results in roughly one‑third the time. This efficiency not only frees up exam rooms but also enhances diagnostic confidence, as automated data capture reduces operator variability.

From a market perspective, PretestPro positions Heru at the intersection of AI, wearable tech, and tele‑ophthalmology. As eye‑care providers seek scalable solutions to meet rising demand—particularly in underserved regions—the ability to conduct comprehensive pre‑testing outside traditional clinics could drive broader adoption. Competitors are introducing similar VR‑based tools, but Heru’s FDA‑registered, patent‑backed platform and its integration with a broader suite of visual assessments may offer a competitive edge. Continued validation and real‑world deployment will determine whether this technology reshapes standard ophthalmic workflows and accelerates the shift toward decentralized vision care.